Wall St. tumbles on global growth worries, J&J decline

Go back to Wall St. tumbles on global growth worries, J&J decline

Morgan Stanley Remains Sidelined on Johnson & Johnson (JNJ) Following Reuters Article

December 17, 2018 8:45 AM EST

Morgan Stanley analyst, David Lewis, reiterated an Equalweight rating and $153.00 price target on Johnson & Johnson (NYSE: JNJ) following a Reuters article claiming that Johnson & Johnson knew for decades that asbestos was in its Baby Powder product. Lewis is not convinced that the article... More

Citi Notes Johnson & Johnson (JNJ) completely refutes premise of Reuters article

December 14, 2018 12:46 PM EST

Citi analyst Amit Hazan notes Johnson & Johnson (NYSE: JNJ) completely refutes the premise of Reuters article.

... More

UPDATE: JP Morgan defended Johnson & Johnson (JNJ) on Talc headlines

December 14, 2018 12:20 PM EST

(Updated - December 16, 2018 1:16 PM EST)

(updated to add analyst name and comment\0

JP Morgan defended Johnson & Johnson (NYSE: JNJ) on Talc headlines.

Analyst Chris Scott remains Neutral rated and notes that all issues reported were previously disclosed by the... More